Mondi: Trading update Q3 2023

Mondi plc, a global leader in the production of sustainable packaging and paper, today provides an update on trading for the three months to 30 September 2023 (“third quarter” or “Q3 2023”).

In the third quarter of 2023 the challenging market conditions continued as expected in light of the ongoing weak macro-economic environment. Market demand has remained soft with lower average selling prices largely mitigated by lower input costs and tight fixed cost control. A much-reduced forestry fair value gain resulted in a lower underlying EBITDA of €261 million when compared to Q2 2023.

In Corrugated Packaging, containerboard prices were stable with our order books improving. Flexible Packaging saw further price and volume declines in kraft paper, which is traditionally later cycle. Our converting network delivered a resilient performance. Uncoated Fine Paper pricing continued to decline in Europe on ongoing weakness in demand. Southern Africa markets remain stable. The forestry fair value gain, accounted for within uncoated fine paper, was €14 million in Q3 2023, significantly lower than Q2 2023 of €72 million.
details at: https://www.mondigroup.com/news-and-insight/2023/trading-update-q3-2023/

Related Posts

Intertape Polymer Group Reports 2017 Fourth Quarter and Annual Results

Fourth Quarter 2017 Highlights (as compared to fourth quarter 2016): • Revenue increased 13.1% to $237.4 million primarily due to additional revenue from the Cantech Acquisition (1), an increase in average selling price, including the impact of product mix, and an increase in sales volume. • Gross margin decreased to 22.8% from 25.6% primarily due to the non-recurrence of Insurance Proceeds (2). Gross margin in the fourth quarter of 2016 would have been 21.7% excluding the impact of the Insurance Proceeds. Fourth Quarter 2017 Highlights (as compared to fourth quarter 2016): • Revenue increased 13.1% to $237.4 million primarily due to additional revenue from the Cantech Acquisition (1), an increase in average selling price, including the impact of product mix, and an increase in sales volume. • Gross margin decreased to 22.8% from 25.6% primarily due to the non-recurrence of Insurance Proceeds (2). Gross margin in the fourth quarter of 2016 would have been 21.7% excluding the impact of the Insurance Proceeds. Click Read More below for additional information.

Cascades Reports Results for the Third Quarter of 2022

Q3 2022 Highlights *Sales of $1,174 million (compared with $1,119 million in Q2 2022 and $1,030 million in Q3 2021) **As reported (including specific items) *Operating income of $25 million (compared with $32 million in Q2 2022 and $73 million in Q3 2021) *Operating income before depreciation and amortization (OIBD) of $92 million (compared with $95 million in Q2 2022 and $136 million in Q3 2021)

Amcor develops breakthrough recyclable healthcare packaging

Building on its recent track record of breakthrough innovations to deliver recyclable packaging, Amcor is today announcing customer trials of the world’s first recyclable* Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint, when compared to packaging alternatives on the market today.** AmSky™ eliminates PVC (PolyVinyl Chloride) from the packaging by using a mono-material Polyethylene (PE) thermoform blister and lidding film. PVC can make packaging recycling more difficult or contaminate other materials if consumers attempt to recycle it. By removing PVC – whilst retaining all the benefits of pre-existing blister packaging – Amcor has created a new, recyclable solution that benefits the entire recycling process. Amcor is currently working with several leading pharmaceutical companies to bring AmSky™ to market globally. The company expects AmSky™ to be available in the healthcare market by the second half of 2022.
Back To Top
×Close search
Search